Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Apicella

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
British Journal of Cancer|August 15, 2013
Prospective validation of the breast cancer risk prediction model BOADICEA and a batch-mode version BOADICEACentreR J MacInnis, A Bickerstaffe, C Apicella, et al.
Clinical Genetics|July 31, 2007
Validation study of the LAMBDA model for predicting the BRCA1 or BRCA2 mutation carrier status of North American Ashkenazi Jewish womenC Apicella, J G Dowty, G S Dite, et al.
Pathology|December 27, 2011
Using tumour pathology to identify people at high genetic risk of breast and colorectal cancersJ L Hopper, M A Jenkins, J G Dowty, et al.
British Journal of Cancer|June 22, 2013
Tumour morphology predicts PALB2 germline mutation statusZ L Teo, E Provenzano, G S Dite, et al.
British Journal of Cancer|October 29, 2011
Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer riskK N Stevens, M Garcia-Closas, Z Fredericksen, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
British Journal of Cancer|August 15, 2013
Prospective validation of the breast cancer risk prediction model BOADICEA and a batch-mode version BOADICEACentreR J MacInnis, A Bickerstaffe, C Apicella, et al.
Clinical Genetics|July 31, 2007
Validation study of the LAMBDA model for predicting the BRCA1 or BRCA2 mutation carrier status of North American Ashkenazi Jewish womenC Apicella, J G Dowty, G S Dite, et al.
Pathology|December 27, 2011
Using tumour pathology to identify people at high genetic risk of breast and colorectal cancersJ L Hopper, M A Jenkins, J G Dowty, et al.
British Journal of Cancer|June 22, 2013
Tumour morphology predicts PALB2 germline mutation statusZ L Teo, E Provenzano, G S Dite, et al.
British Journal of Cancer|October 29, 2011
Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer riskK N Stevens, M Garcia-Closas, Z Fredericksen, et al.
Pageof 3